title: HIV protease inhibitors increase adiponectin levels in HIV-negative men.
authors.forename: Grace A
authors.initials: GA
authors.lastname: Lee
authors.forename: Derek D
authors.initials: DD
authors.lastname: Mafong
authors.forename: Mustafa A
authors.initials: MA
authors.lastname: Noor
authors.forename: Joan C
authors.initials: JC
authors.lastname: Lo
authors.forename: Kathleen
authors.initials: K
authors.lastname: Mulligan
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Schwarz
authors.forename: Morris
authors.initials: M
authors.lastname: Schambelan
authors.forename: Carl
authors.initials: C
authors.lastname: Grunfeld
mesh_terms: D052242:Adiponectin; D004338:Drug Combinations; D017320:HIV Protease Inhibitors / Q000633:toxicity*; D018023:HIV Seronegativity; D006801:Humans; D019469:Indinavir / Q000633:toxicity; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000633:toxicity; D019438:Ritonavir / Q000633:toxicity
chemical_list: D052242:Adiponectin; D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D036341:Intercellular Signaling Peptides and Proteins; D011744:Pyrimidinones; D061466:Lopinavir; D019469:Indinavir; D019438:Ritonavir